A comparison of parametric and non-parametric approaches to target-controlled infusion of propofol

Anaesthesia and Intensive Care

Volumn 38, Issue 3, 2010, Pages 437-444

  Crankshaw, D P ^a   Brown, M J ^a   Bjorksten, A R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Clinical methods; Infusion pharmacokinetics; NONMEM; Plasma drug efflux

Indexed keywords

PROPOFOL;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; HUMAN; LEAN BODY WEIGHT; MALE;

EID: 77952960304     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x1003800305     Document Type: Article

References (21)

1. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66:1256-1263. (Pubitemid 18024603)
2. Marsh B, White M, Morton N, Kenny GNC. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67:41-48.
3. Longnecker DE, Brown DL, Newman MF, Zapol WM. Anesthesiology, McGraw-Hill Professional Publishing, 2007; p. 891.
4. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90:1502-1516.
5. Stanpump® (Steven L. Shafer: Stanford University Anesthesiology Service, 112A PAVAMC, 3801 Miranda Ave, Palo Alto, CA 94304, USA).
6. Davidson JAH, Macleod AD, Howie JC, White M, Kenny GNC. Effective concentration 50 for propofol with and without 67% nitrous oxide. Acta Anaesthesiol Scand 1993; 37:458-464. (Pubitemid 23203954)
7. Schüttler J, Ihmsen H. Population pharmacokinetics of propofol. Anesthesiology 2000; 92:727-738.
8. Glen JB, Servin F. Evaluation of the predictive performance of four pharmacokinetic models for propofol. Br J Anaesth 2009; 102:626-632.
9. Crankshaw DP, Boyd MD, Bjorksten AR. Plasma Drug efflux - a new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital. Anesthesiology 1987; 67:32-41.
10. Crankshaw DP. Variability and anaesthetic agents. Anaesthetic Pharmacology Review 1994; 2:271-279.
11. James WPT. Research on obesity. London: Her Majesty's Stationary Office 1976.
12. Crankshaw DP, Morgan DJ, Beemer GH, Karasawa F. Preprogrammed infusion of alfentanil to constant arterial plasma concentration. Anesth Analg 1993; 76:556-561. (Pubitemid 23077115)
13. Beal SL, Scheiner LB. NONMEM User's Guide. San Francisco, University of California San Francisco 1979.
14. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88:1170-1182. (Pubitemid 28216859)
15. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. I Models for covariate effects. J Pharmacokinet Biopharm 1992; 20:511-528. (Pubitemid 23034413)
16. Jonsson EN, Karlsson MO. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 1999; 58:51-64.
17. Hull CJ. Pharmacokinetics for Anaesthesia. Butterworth Heineman 1991; p. 196.
18. Crankshaw DP, Karasawa F. A method for implementing programmed infusion of thiopentone and methohexitone with a simple infusion pump. Anaesth Intensive Care 1989; 17:496-499.
19. Glass PSA, Shafer SL, Reves JG. Intravenous delivery systems. In: Miller RD, ed. Anesthesia, 5th ed. Philadelphia, Churchill Livingstone Publishers 2000. p. 377-411.
20. Crankshaw DP, Intravenous delivery systems: Australian Perspective. In: White PF, ed. Intravenous Anaesthesia. Williams & Wilkins, Media PA 1997. p. 539-544.
21. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic pharmacodynamic model. Anesthesiology 2001; 95:324-333.